HomeClinical TopicsFDA approves new injectable drug for schizophrenia

FDA approves new injectable drug for schizophrenia

On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content